Literature DB >> 10527928

Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P.

F Tamanini1, L Van Unen, C Bakker, N Sacchi, H Galjaard, B A Oostra, A T Hoogeveen.   

Abstract

The absence of fragile-X mental-retardation protein (FMRP) results in fragile-X syndrome. Two other fragile-X-related (FXR) proteins have been described, FXR1P and FXR2P, which are both very similar in amino acid sequence to FMRP. Interaction between the three proteins as well as with themselves has been demonstrated. The FXR proteins are believed to play a role in RNA metabolism. To characterize a possible functional role of the interacting proteins the complex formation of the FXR proteins was studied in mammalian cells. Double immunofluorescence analysis in COS cells over-expressing either FMRP ISO12/FXR1P or FMRP ISO12/FXR2P confirmed heterotypic interactions. However, Western-blotting studies on cellular homogenates containing physiological amounts of the three proteins gave different indications. Gel-filtration experiments under physiological as well as EDTA conditions showed that the FXR proteins were in complexes of >600 kDa, as parts of messenger ribonuclear protein (mRNP) particles associated with polyribosomes. Salt treatment shifted FMRP, FXR1P and FXR2P into distinct intermediate complexes, with molecular masses between 200 and 300 kDa. Immunoprecipitations of FMRP as well as FXR1P from the dissociated complexes revealed that the vast majority of the FXR proteins do not form heteromeric complexes. Further analysis by [(35)S]methionine labelling in vivo followed by immunoprecipitation indicated that no proteins other than the FXR proteins were present in these complexes. These results suggest that the FXR proteins form homo-multimers preferentially under physiological conditions in mammalian cells, and might participate in mRNP particles with separate functions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527928      PMCID: PMC1220581     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Binding of Xenopus oocyte masking proteins to mRNA sequences.

Authors:  K Marello; J LaRovere; J Sommerville
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations.

Authors:  F Tamanini; C Bontekoe; C E Bakker; L van Unen; B Anar; R Willemsen; M Yoshida; H Galjaard; B A Oostra; A T Hoogeveen
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

4.  A point mutation in the FMR-1 gene associated with fragile X mental retardation.

Authors:  K De Boulle; A J Verkerk; E Reyniers; L Vits; J Hendrickx; B Van Roy; F Van den Bos; E de Graaff; B A Oostra; P J Willems
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

5.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.

Authors:  H Siomi; M C Siomi; R L Nussbaum; G Dreyfuss
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

6.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

7.  Mammalian heterogeneous ribonucleoprotein A1 and its constituent domains. Nucleic acid interaction, structural stability and self-association.

Authors:  J R Casas-Finet; J D Smith; A Kumar; J G Kim; S H Wilson; R L Karpel
Journal:  J Mol Biol       Date:  1993-02-20       Impact factor: 5.469

8.  Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome.

Authors:  H Siomi; M Choi; M C Siomi; R L Nussbaum; G Dreyfuss
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

9.  Characterization and localization of the FMR-1 gene product associated with fragile X syndrome.

Authors:  C Verheij; C E Bakker; E de Graaff; J Keulemans; R Willemsen; A J Verkerk; H Galjaard; A J Reuser; A T Hoogeveen; B A Oostra
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

10.  Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box.

Authors:  M Kiledjian; G Dreyfuss
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more
  28 in total

1.  RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1.

Authors:  Dillon Fritz; Branko Stefanovic
Journal:  J Mol Biol       Date:  2007-06-09       Impact factor: 5.469

2.  Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.

Authors:  R Lane Coffee; Charles R Tessier; Elvin A Woodruff; Kendal Broadie
Journal:  Dis Model Mech       Date:  2010-05-04       Impact factor: 5.758

3.  Recombinant bacterial expression and purification of human fragile X mental retardation protein isoform 1.

Authors:  Timothy L Evans; Mihaela-Rita Mihailescu
Journal:  Protein Expr Purif       Date:  2010-06-10       Impact factor: 1.650

4.  The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.

Authors:  François Rousseau; Yves Labelle; Johanne Bussières; Carmen Lindsay
Journal:  Clin Biochem Rev       Date:  2011-08

5.  Fmr1 KO and fenobam treatment differentially impact distinct synapse populations of mouse neocortex.

Authors:  Gordon X Wang; Stephen J Smith; Philippe Mourrain
Journal:  Neuron       Date:  2014-12-17       Impact factor: 17.173

6.  Hypervariable Domain of Eastern Equine Encephalitis Virus nsP3 Redundantly Utilizes Multiple Cellular Proteins for Replication Complex Assembly.

Authors:  Ilya Frolov; Dal Young Kim; Maryna Akhrymuk; James A Mobley; Elena I Frolova
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

7.  A study of the ultrastructure of fragile-X-related proteins.

Authors:  Ljiljana Sjekloća; Petr V Konarev; John Eccleston; Ian A Taylor; Dmitri I Svergun; Annalisa Pastore
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

8.  Fragile X granules are a family of axonal ribonucleoprotein particles with circuit-dependent protein composition and mRNA cargos.

Authors:  Eunice Chyung; Hannah F LeBlanc; Justin R Fallon; Michael R Akins
Journal:  J Comp Neurol       Date:  2017-09-20       Impact factor: 3.215

Review 9.  Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction.

Authors:  Marta Prieto; Alessandra Folci; Stéphane Martin
Journal:  Mol Psychiatry       Date:  2019-12-10       Impact factor: 15.992

10.  Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs.

Authors:  Jennifer C Darnell; Claire E Fraser; Olga Mostovetsky; Robert B Darnell
Journal:  Hum Mol Genet       Date:  2009-06-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.